Ewa Obuchowicz | Pharmacology | Best Researcher Award

Ewa Obuchowicz | Pharmacology | Best Researcher Award

Prof. Ewa Obuchowicz, Medical University of Silesia, Poland

Prof. Ewa Obuchowicz is the Head of the Department of Pharmacology at the Faculty of Medical Sciences in Katowice, Medical University of Silesia. She earned her M.Sc. in 1979, Ph.D. in 1985, became an Associate Professor in 2001, and a Professor in 2011. Her research focuses on psychotropic drugs, neuropeptides, cytokines, and glioblastoma therapy πŸ§ πŸ”¬. She has authored 89 scientific papers, with over 2,000 citations and an h-index of 20. A recipient of multiple awards πŸ†, she is an esteemed member of the Polish Pharmacological Society.

Publication Profile

Scopus

Education

Prof. Ewa Obuchowicz πŸŽ“ is a distinguished expert in pharmacology, with an impressive academic journey spanning decades. She earned her M.Sc. in 1979, followed by a Ph.D. in 1985, and attained full professorship in 2011. As the Head of the Department of Pharmacology at the Faculty of Medical Sciences in Katowice, Medical University of Silesia πŸ₯, she exemplifies leadership and dedication to advancing medical research. Her extensive contributions and unwavering commitment to the field make her a strong candidate for the Best Researcher Award πŸ†, highlighting her impact on academia and scientific progress.

ExperienceΒ 

Prof. Ewa Obuchowicz πŸ”¬ is a renowned researcher specializing in psychotropic drug mechanisms, neuropeptides, cytokines, and glial cell protein expression. Her work delves into the complex interplay between stress, immunostimulation, and neurotrophic factors 🧠, shedding light on crucial neurological processes. Additionally, she has explored the role of the endocannabinoid system 🌿 and contributed to developing innovative adjuvant therapies for glioblastoma πŸŽ—οΈ. Her groundbreaking research plays a vital role in advancing medical and pharmacological sciences, solidifying her reputation as a distinguished scientist in the field. Her dedication continues to shape the future of neuropharmacology and therapeutic innovation.

Scientific Achievements

Prof. Ewa Obuchowicz πŸ“š has made a remarkable impact on the scientific community with 89 full-length publications, 71 of which have been cited over 2,000 times. With an h-index of 20 (Scopus) πŸ“Š, her research has gained widespread recognition. Notably, five of her papers have been cited over 100 times, highlighting their profound influence. Beyond research articles, she has contributed to authoritative pharmacology handbooks πŸ“–, further solidifying her scholarly excellence. Her outstanding publication record and significant contributions to the field make her a deserving candidate for the award πŸ†, reflecting her dedication to advancing pharmacological sciences.

Professional Memberships

Prof. Ewa Obuchowicz 🀝 is an active member of the Polish Pharmacological Society, where she contributes to professional discussions and advancements in pharmacology. Through her engagement with research organizations πŸ›οΈ, she fosters collaboration and drives progressive scientific discoveries. Her dedication to the field extends beyond her own research, as she actively participates in shaping the future of pharmacology through knowledge exchange and professional networking. By staying at the forefront of scientific discourse, she continuously enhances the impact of her work, reinforcing her role as a key contributor to the advancement of medical and pharmacological sciences.

Awards

Prof. Ewa Obuchowicz πŸ… has received prestigious recognition for her outstanding contributions to medical and pharmacological research. She has been honored with two Scientific Awards from the Minister of Health and Social Welfare πŸ† and thirteen Scientific Awards from the Rector of the Medical University of Silesia in Katowice πŸŽ–οΈ. These accolades reflect her dedication, innovation, and impact in the field. Her groundbreaking research and scholarly achievements continue to shape the future of pharmacology, further solidifying her candidacy for the Best Researcher Award πŸ… and reinforcing her status as a leading figure in medical science.

Research Focus

Professor Ewa Obuchowicz is a distinguished neuroscientist specializing in psychopharmacology πŸ§ πŸ’Š, with a research focus on depression, stress, and the endocannabinoid system. Her work explores the mechanisms of antidepressants, particularly escitalopram, and their effects on neurotransmission, gene expression, and behavioral responses. She has contributed significantly to preclinical models of stress and mood disorders, investigating the role of neuropeptides, oxytocin, and the hypothalamus-pituitary-gonadal (HPG) axis πŸ”¬πŸ“Š. Additionally, her research extends to neuro-oncology, examining glioblastoma treatments. Through her studies, she aims to advance mental health therapeutics and improve understanding of stress-induced disorders.

Publication Top Notes

Escitalopram reverses anxiety-like and despair behavior and affects endocannabinoid-related genes expression in the brain of adolescent male rats subjected to early life stress

Acute Stress Affects the Relaxin/Insulin-Like Family Peptide Receptor 3 mRNA Expression in Brain of Pubertal Male Wistar Rats

How depression and antidepressant drugs affect endocannabinoid system?β€”review of clinical and preclinical studies

A Dot-Blot Screening for Identifying the Temozolomide-Regulated Proteins as Potential Targets for Glioma Multi-OMICS Studies

Escitalopram alters the hypothalamic OX system but does not affect its up-regulation induced by early-life stress in adult rats.

Neuropeptides as regulators of the hypothalamus-pituitary-gonadal (HPG) axis activity and their putative roles in stress-induced fertility disorders

Glucose Influences the Response of Glioblastoma Cells to Temozolomide and Dexamethasone

May application of oxytocin be relevant in the therapy of perinatal mental disorders?

Tang Jin-Bao | Pharmacology | Best Researcher Award

Tang Jin-Bao | Pharmacology | Best Researcher Award

Prof. Dr Tang Jin-Bao,Shandong Second Medical University,China

Prof. Dr. Jin-Bao Tang, a licensed pharmacist in China, is a professor at Shandong Second Medical University. He earned his Ph.D. in Microbial and Biochemical Pharmacy from Shandong University in 2023. An esteemed graduate sponsor in Shandong Province, he specializes in Biotechnological Pharmaceutics and Pharmaceutical Engineering. His research focuses on developing novel immunoassay biosensors for proteins and peptides. With multiple high-impact publications in Food Chemistry and Analytical Bioanalytical Chemistry, he has pioneered advanced immunosensor technologies. His innovative contributions to biosensor development enhance precision in food safety and biomedical analysis. πŸ”¬πŸ“š

Publication Profile

Scopus

Education

Prof. Dr. Jin-Bao Tang πŸŽ“ holds a Doctorate in Microbial and Biochemical Pharmacy from Shandong University (2023) and is a licensed pharmacist in China. As a distinguished professor at Shandong Second Medical University, he plays a vital role in educating future pharmaceutical professionals in Biotechnological Pharmaceutics and Pharmaceutics Engineering πŸ§ͺ. His dedication to academia is evident through his mentorship and contributions to pharmaceutical sciences. Recognized as an excellent graduate sponsor of Shandong Province πŸ†, Dr. Tang’s expertise and commitment continue to shape the next generation of researchers and industry leaders in the field of pharmacy. πŸ’Š

Scientific Community

Prof. Dr. Jin-Bao Tang πŸ§‘β€πŸ”¬ has made a significant impact in the scientific community through his groundbreaking research in biotechnology and pharmacology. His publications appear in prestigious journals such as Food Chemistry, International Journal of Biological Macromolecules, Food Control, and Analytical Bioanalytical Chemistry πŸ“š. His collaborative work has led to advancements in oriented antibody immobilization, photoconjugation strategies, and biosensor technology πŸ§ͺ, with profound implications for public health, biotechnology, and pharmacological applications. Through his innovative contributions, Prof. Tang continues to shape the future of pharmaceutical sciences, enhancing diagnostic and therapeutic approaches for global healthcare. πŸŒπŸ’Š

Research Contributions

Prof. Dr. Tang Jin-Bao’s research revolves around developing novel immunoassay biosensors for protein and peptide detection πŸ§ͺπŸ”¬. His pioneering work has significantly advanced biosensing technology, particularly in food safety and biomedical analysis πŸŽβš•οΈ. Over the past five years, his high-impact publications have introduced innovative techniques such as electrochemical immunosensors for aflatoxin detection ⚑, bioluminescent immunoassays using antibody-nanoluciferase conjugates ✨, and Fc-specific antibody modifications for enhanced biosensor performance 🧫. Additionally, his photoconjugation strategies have led to stable fluorescent antibody fabrication 🌟. These breakthroughs contribute immensely to food safety, pharmaceutical analysis, and immunodiagnostics, demonstrating the real-world impact of his research. πŸš€

Research Focus

Prof. Dr. Jin-Bao Tang’s research primarily focuses on biosensors πŸ§ͺ, immunoassays πŸ₯, and antibody engineering 🧬 for food safety and biomedical applications. His work involves developing electrochemical immunosensors ⚑, bioluminescent assays πŸ’‘, and advanced antibody modifications πŸ—οΈ to enhance the detection of harmful contaminants like aflatoxin B1 πŸ„βš οΈ. He explores oriented antibody immobilization 🎯 to improve sensitivity and specificity in bioanalytical methods. Additionally, his research extends to drug delivery systems πŸ’Š, particularly in pulsatile release formulations ⏳, using innovative polymers. His contributions advance food safety πŸ₯—, biomedical diagnostics πŸ₯, and pharmaceutical technologies πŸ’Š for global health and safety.

Publication Top Notes

A facile and effective electrochemical immunosensor based on controlled and oriented immobilization of natural antibodies for sensitive detection of aflatoxin B1

Development of a bioluminescent immunoassay based on Fc-specific conjugated antibody–nanoluciferase immunoreagents for determining aflatoxin B1

Fabrication of cysteine-modified antibodies with Fc-specific conjugation for covalent and oriented immobilization of native antibodies

Preparation of enteric capsules with pulsatile drug delivery potential using pullulan and polyacrylic acid resin III